Colecalciferol
Fosamax Plus D (cholecalciferol) is a small molecule pharmaceutical. Cholecalciferol was first approved as Fosamax Plus D on 2005-04-07. It is used to treat cardiovascular diseases, chronic kidney failure, crohn disease, familial hypophosphatemic rickets, and hypoparathyroidism amongst others in the USA.
| Trade Name | Fosamax Plus D |
|---|---|
| Common Name | Colecalciferol |
| Indication | cardiovascular diseases, chronic kidney failure, crohn disease, familial hypophosphatemic rickets, hypoparathyroidism, lung neoplasms, osteoporosis, psoriasis, skin neoplasms |
| Drug Class | Vitamin D analogues |
